Stock Updates: Latest Developments

7 / 100

Stock Updates: Latest Developments in Indian Companies

Company	Update
Maruti Suzuki India	Received an adjudication order upholding Rs 174 crore GST demand; will file an appeal.
LTI Mindtree	Faced a Rs 206 crore tax demand from Mumbai tax authorities.
MRF	To acquire a 27.2% stake in First Energy 8 for Rs 35.8 crore to boost renewable power supply.
Dhampur Sugar Mills Ltd	Board approved buyback through a tender offer at Rs. 300/share; Record Date set for January 17, 2024.
Rashtriya Chemicals & Fertilizers	Received Environmental Clearance for setting up a new 1200 MTPD complex fertilizer plant in Thal, Maharashtra.
BASF India Limited	Received Show Cause Notice raising a total demand of Rs. 282.58 Crs for FY 2017-18.
Vedanta	Recorded aluminum output at 599 KT, refined zinc output at 203 KT, and raised Rs 3,400 crores via private placement of NCDs.
Ujjivan Small Finance Bank	Total deposits at Rs 29,869 crore (up 29% YoY), and disbursements at Rs 5,675 crore (up 17% YoY).
NHPC	Signed MoU with Gujarat Power Corp for a Rs 4,000 crore investment in the 750 MW Kuppa Pumped Storage Project.
Indian Energy Exchange	Q3 overall volume at 28,326 MU (up 16.9% YoY), December overall volume at 9,707 MU (up 14.9% YoY).
Torrent Power	Signed four MoUs worth Rs 47,350 crore with the Gujarat government.
JIO Financial Services	Filed for a mutual fund license with SEBI along with Blackrock financial management.

These updates provide a snapshot of the diverse activities and financial moves in various sectors, influencing the market dynamics.

Finance Bank, NHPC, Indian Energy Exchange, Torrent Power, JIO Financial Services.

Table of Contents

Nifty only 36 points away from new life time high STAY CAUTIUS AT HIGH PROFIT BOOKING POSSIBLE SHARP FALL #StockMarket #FinancialNews #Trading Nifty only 36 points away from new life time high STAY CAUTIUS AT HIGH PROFIT BOOKING POSSIBLE SHARP FALL #StockMarket #FinancialNews #Trading

July 26, 2024 No Comments

Nifty only 36 points away from new life time high STAY CAUTIUS AT HIGH PROFIT BOOKING POSSIBLE SHARP FALL #StockMarket #FinancialNews #Trading Nifty only 36

Market@ noon Nifty up by 240 points (+0.90%) Top Gainers : ADANIENSOL +4.65%, SBILIFE +4.13% Top Losers : UNITDSPR -1.65%, ONGC -1.04% #StockMarket #FinancialNews #Trading Market@ noon Nifty up by 240 points (+0.90%) Top Gainers : ADANIENSOL +4.65%, SBILIFE +4.13% Top Losers : UNITDSPR -1.65%, ONGC -1.04% #StockMarket #FinancialNews #Trading

July 26, 2024 No Comments

Market@ noonNifty up by 240 points (+0.90%) Top Gainers : ADANIENSOL +4.65%, SBILIFE +4.13% Top Losers : UNITDSPR -1.65%, ONGC -1.04% #StockMarket #FinancialNews #Trading Market@

Market Alert | Nifty metal up over 3% led by Adani Ent , Vedanta; registers biggest single session gain in 1 month Nifty crosses 24,800 mark; less than 50 points away from record high #StockMarket #FinancialNews #Trading Market Alert | Nifty metal up over 3% led by Adani Ent , Vedanta; registers biggest single session gain in 1 month Nifty crosses 24,800 mark; less than 50 points away from record high #StockMarket #FinancialNews #Trading

July 26, 2024 No Comments

Market Alert | Nifty metal up over 3% led by Adani Ent , Vedanta; registers biggest single session gain in 1 month Nifty crosses 24,800

ALEMBIC PHARMA: CO SAYS GMP INSPECTION AT PANELAV FACILITY WAS SUCCESSFULLY COMPLETED WITHOUT ANY FORM 483 OBSERVATION #StockMarket #FinancialNews #Trading ALEMBIC PHARMA: CO SAYS GMP INSPECTION AT PANELAV FACILITY WAS SUCCESSFULLY COMPLETED WITHOUT ANY FORM 483 OBSERVATION #StockMarket #FinancialNews #Trading

July 26, 2024 No Comments

ALEMBIC PHARMA: CO SAYS GMP INSPECTION AT PANELAV FACILITY WAS SUCCESSFULLY COMPLETED WITHOUT ANY FORM 483 OBSERVATION #StockMarket #FinancialNews #Trading ALEMBIC PHARMA: CO SAYS GMP

#SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading #SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading

July 26, 2024 No Comments

#SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia